| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2017 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 10,000 | $2.23 | $22,300.00 | +3.4% | |
| Sep 21, 2017 | AVDL Avadel Pharmaceuticals Plc | Thornton Peter J. | Director | Buy | 5,155 | $9.74 | $50,214.85 | New | |
| Sep 18, 2017 | BCRX Biocryst Pharmaceuticals Inc | Cohen Fred E | Director | Sell | 54,250 | $5.42 | $294,035.00 | -31.2% | |
| Sep 15, 2017 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 190,000 | $82.53 | $15,679,771.99 | - | |
| Sep 15, 2017 | PAHC Phibro Animal Health Corp | Warras Dean J | Pres Animal Health &Nutr N.a. | Sell | 10,000 | $35.70 | $357,008.00 | -64.1% | |
| Sep 14, 2017 | PAHC Phibro Animal Health Corp | Miller Larry Lee | Chief Operating Officer | Sell | 21,439 | $36.43 | $781,000.18 | -100% | |
| Sep 14, 2017 | PAHC Phibro Animal Health Corp | Johnson Richard G | Chief Financial Officer | Sell | 55,529 | $36.30 | $2,015,472.67 | -100% | |
| Sep 14, 2017 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 25,000 | $38.50 | $962,500.00 | -0.8% | |
| Sep 14, 2017 | AVDL Avadel Pharmaceuticals Plc | Hatten Sandra L | See Remarks | Buy | 6,000 | $9.25 | $55,524.90 | +5.7% | |
| Sep 13, 2017 | AVDL Avadel Pharmaceuticals Plc | Thompson Phillandas T. | See Remarks | Buy | 5,000 | $9.36 | $46,800.00 | +8.6% | |
| Sep 13, 2017 | LNTH Lantheus Holdings, Inc. | Schaffer Derace L | Director | Sell | 15,000 | $17.50 | $262,500.00 | -14.0% | |
| Sep 12, 2017 | PRGO Perrigo Co Plc | Needham Jeffrey | EVP, President Chc Americas | Sell | 3,595 | $89.49 | $321,706.96 | -15.3% | |
| Sep 12, 2017 | AVDL Avadel Pharmaceuticals Plc | Stapleton Craig R | Director | Buy | 20,000 | $9.52 | $190,360.00 | +22.2% | |
| Sep 12, 2017 | PRGO Perrigo Co Plc | Janish Ronald Craig61 | EVP, Global Op. &Supply Chain | Sell | 261 | $88.71 | $23,153.92 | -7.3% | |
| Sep 12, 2017 | AVDL Avadel Pharmaceuticals Plc | Anderson Michael S | Chief Executive Officer | Buy | 4,000 | $9.80 | $39,180.00 | +1.8% | |
| Sep 12, 2017 | AVDL Avadel Pharmaceuticals Plc | Divis Greg J71 | See Remarks | Buy | 10,600 | $9.32 | $98,760.20 | New | |
| Sep 12, 2017 | PAHC Phibro Animal Health Corp | Johnson Richard G | Chief Financial Officer | Sell | 47,264 | $36.32 | $1,716,455.59 | -100% | |
| Sep 12, 2017 | PAHC Phibro Animal Health Corp | Miller Larry Lee | Chief Operating Officer | Sell | 46,102 | $36.33 | $1,674,693.10 | -100% | |
| Sep 11, 2017 | TLPH Talphera, Inc. | Asadorian Raffi | Chief Financial Officer | Buy | 7,000 | $3.24 | $22,705.20 | New | |
| Sep 11, 2017 | ALKS Alkermes Plc. | Biberstein Kathryn L | Evp/ Cao/ CCO Alks Inc; Sec Alks | Sell | 13,566 | $51.29 | $695,817.06 | -10.4% | |
| Sep 11, 2017 | LNTH Lantheus Holdings, Inc. | Duffy Michael P | See Remarks | Sell | 20,000 | $16.45 | $328,978.00 | -10.9% | |
| Sep 11, 2017 | PAHC Phibro Animal Health Corp | Carlson Gerald K | Director | Sell | 5,400 | $36.27 | $195,858.00 | -100% | |
| Sep 8, 2017 | EBS Emergent Biosolutions Inc. | Havey Adam | EVP, Business Operations | Sell | 7,885 | $37.06 | $292,242.54 | -23.2% | |
| Sep 8, 2017 | SUPN Supernus Pharmaceuticals, Inc. | Bhatt Padmanabh P.69 | Sr VP Of Ip, CSO | Sell | 5,000 | $49.86 | $249,302.50 | -28.6% | |
| Sep 8, 2017 | SUPN Supernus Pharmaceuticals, Inc. | Patrick Gregory S | VP, Chief Financial Officer | Sell | 50,000 | $47.60 | $2,379,779.46 | -72.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.